Cargando…
Performance of Copeptin for Early Diagnosis of Acute Coronary Syndromes: A Systematic Review and Meta-Analysis of 14,139 Patients
Diagnosis of acute coronary syndrome (ACS) based on copeptin level may enable one to confirm or rule-out acute myocardial infarction (AMI) with higher sensitivity and specificity, which may in turn further reduce mortality rate and decrease the economic costs of ACS treatment. We conducted a systema...
Autores principales: | Szarpak, Lukasz, Lapinski, Marcin, Gasecka, Aleksandra, Pruc, Michal, Drela, Wiktoria L., Koda, Mariusz, Denegri, Andrea, Peacock, Frank W., Jaguszewski, Miłosz J., Filipiak, Krzysztof J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8780262/ https://www.ncbi.nlm.nih.gov/pubmed/35050216 http://dx.doi.org/10.3390/jcdd9010006 |
Ejemplares similares
-
The diagnostic and prognostic value of copeptin in patients with acute ischemic stroke and transient ischemic attack: A systematic review and meta-analysis
por: Blek, Natasza, et al.
Publicado: (2022) -
Correlation between takotsubo cardiomyopathy and SARS-CoV-2 infection
por: Szarpak, Lukasz, et al.
Publicado: (2021) -
Milrinone or dobutamine in patients with heart failure: evidence from meta‐analysis
por: Szarpak, Lukasz, et al.
Publicado: (2022) -
Post-COVID-19 heart syndrome
por: Gasecka, Aleksandra, et al.
Publicado: (2021) -
Efficacy and safety of levosimendan and dobutamine in heart failure: A systematic review and meta-analysis
por: Jaguszewski, Milosz J., et al.
Publicado: (2021)